These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 8643219
1. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma. Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S. Oncology; 1996; 53(3):182-91. PubMed ID: 8643219 [Abstract] [Full Text] [Related]
2. Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer. Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S. Anticancer Res; 1997; 17(4B):2923-6. PubMed ID: 9329565 [Abstract] [Full Text] [Related]
3. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer. Lundin J, Nordling S, von Boguslawsky K, Roberts PJ, Haglund C. Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843 [Abstract] [Full Text] [Related]
4. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, Androulakis GA. J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009 [Abstract] [Full Text] [Related]
5. Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer. Setälä LP, Nordling S, Kosma VM, Lipponen PK, Eskelinen MJ, Hollmén SM, Syrjänen KJ, Alhava EM. Anal Quant Cytol Histol; 1997 Dec; 19(6):524-32. PubMed ID: 9893908 [Abstract] [Full Text] [Related]
6. Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer. Salud A, Porcel JM, Raikundalia B, Camplejohn RS, Taub NA. J Surg Oncol; 1999 Nov; 72(3):167-74. PubMed ID: 10562364 [Abstract] [Full Text] [Related]
7. Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma. Pinto AE, André S, Pereira T, Nóbrega S, Soares J. J Clin Pathol; 2001 Jul; 54(7):543-9. PubMed ID: 11429427 [Abstract] [Full Text] [Related]
8. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction. Nordström B, Strang P, Bergström R, Nilsson S, Tribukait B. Cancer; 1996 Nov 01; 78(9):1942-51. PubMed ID: 8909315 [Abstract] [Full Text] [Related]
9. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients. Pinto AE, André S, Soares J. J Clin Pathol; 1999 Aug 01; 52(8):604-11. PubMed ID: 10645231 [Abstract] [Full Text] [Related]
10. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer. Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J. Breast Cancer Res Treat; 2005 May 01; 91(1):61-71. PubMed ID: 15868432 [Abstract] [Full Text] [Related]
11. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy. Vesalainen S, Nordling S, Lipponen P, Talja M, Syrjänen K. Br J Cancer; 1994 Aug 01; 70(2):309-14. PubMed ID: 8054280 [Abstract] [Full Text] [Related]
12. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma. Russo A, Bazan V, Migliavacca M, Zanna I, Tubiolo C, Tumminello FM, Dardanoni G, Cajozzo M, Bazan P, Modica G, Latteri M, Tomasino RM, Colucci G, Gebbia N, Leto G. Clin Cancer Res; 2000 Jan 01; 6(1):178-84. PubMed ID: 10656448 [Abstract] [Full Text] [Related]
13. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers. Ohyama S, Yonemura Y, Miyazaki I. Cancer; 1990 Jan 01; 65(1):116-21. PubMed ID: 2293858 [Abstract] [Full Text] [Related]
14. Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma. Karlsson M, Boeryd B, Carstensen J, Frånlund B, Gustafsson B, Kågedal B, Sun XF, Wingren S. Eur J Cancer; 1996 Feb 01; 32A(2):357-62. PubMed ID: 8664054 [Abstract] [Full Text] [Related]
16. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient. Haffty BG, Toth M, Flynn S, Fischer D, Carter D. J Clin Oncol; 1992 Dec 01; 10(12):1839-47. PubMed ID: 1453198 [Abstract] [Full Text] [Related]
17. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. Pfisterer J, Kommoss F, Sauerbrei W, Rendl I, Kiechle M, Kleine W, Pfleiderer A. Gynecol Oncol; 1995 Aug 01; 58(2):149-56. PubMed ID: 7622098 [Abstract] [Full Text] [Related]
18. Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy. Brooks SA, Leathem AJ, Camplejohn RS, Gregory W. Breast Cancer Res Treat; 1993 Aug 01; 25(3):247-56. PubMed ID: 8369526 [Abstract] [Full Text] [Related]
19. Gastric lymphomas in Turkey. Analysis of prognostic factors with special emphasis on flow cytometric DNA content. Aydin ZD, Barista I, Canpinar H, Sungur A, Tekuzman G. Cancer; 2000 Jul 01; 89(1):12-20. PubMed ID: 10896995 [Abstract] [Full Text] [Related]
20. Prognostic significance of proliferative activity, DNA-ploidy, p53 and Ki-ras point mutations in colorectal liver metastases. Russo A, Migliavacca M, Bazan V, Maturi N, Morello V, Dardanoni G, Modica G, Bazan P, Albanese I, La Farina M, Tomasino RM. Cell Prolif; 1998 Jul 01; 31(3-4):139-53. PubMed ID: 9853427 [Abstract] [Full Text] [Related] Page: [Next] [New Search]